Abstract:Background: Glioblastoma (GBM) is a malignant primary brain tumor. This study focused on exploring the exosome-related features of glioblastoma to better understand its cellular composition and molecular characteristics. Methods: Single-cell RNA sequencing (scRNA-seq) and spatial transcriptome RNA sequencing (stRNA-seq) were used to analyze the heterogeneity of glioblastomas. After data integration, cell clustering, and annotation, five algorithms were used to calculate scores for exosome-related genes(ERGs). Cell trajectory analysis and intercellular communication analysis were performed to explore exosome-related communication patterns. Spatial transcriptome sequencing data were analyzed to validate the findings. To further utilize exosome-related features to aid in clinical decision-making, a prognostic model was constructed using GBM's bulk RNA-seq. Results: Different cell subpopulations were observed in GBM, with Monocytes/macrophages and malignant cells in tumor samples showing higher exosome-related scores. After identifying differentially expressed ERGs in malignant cells, pseudotime analysis revealed the cellular status of malignant cells during development. Intercellular communication analysis highlighted signaling pathways and ligand-receptor interactions. Spatial transcriptome sequencing confirmed the high expression of exosome-related gene features in the tumor core region. A prognostic model based on six ERGs was shown to be predictive of overall survival and immunotherapy outcome in GBM patients. Finally, based on the results of scRNA-seq and prognostic modeling as well as a series of cell function experiments, BARD1 was identified as a novel target for the treatment of GBM. Conclusion: This study provides a comprehensive understanding of the exosome-related features of GBM in both scRNA-seq and stRNA-seq, with malignant cells with higher exosome-related scores exhibiting stronger communication with Monocytes/macrophages. In terms of spatial data, highly scored malignant cells were also concentrated in the tumor core region. In bulk RNA-seq, patients with a high exosome-related index exhibited an immunosuppressive microenvironment, which was accompanied by a worse prognosis as well as immunotherapy outcomes. Prognostic models constructed using ERGs are expected to be independent prognostic indicators for GBM patients, with potential implications for personalized treatment strategies for GBM. Knockdown of BARD1 in GBM cell lines reduces the invasive and value-added capacity of tumor cells, and thus BARD1-positively expressing malignant cells are a risk factor for GBM patients.

Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.

Performing Data Mining to Explain the Correlation between the BIRC5 Gene and Prognosis in Breast Cancer Patients

Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

Identified Potential Pathogenic Variants of BARD1 in 1449 Chinese High-Risk Breast Cancer Patients.

Expression of BARD1 in Sporadic Breast Carcinoma of the Female Han Ethnic Group and Its Clinical Significance

A Synergetic Effect of BARD1 Mutations on Tumorigenesis

Functional Polymorphisms in BARD1 Association with Neuroblastoma in a Regional Han Chinese Population

Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient

Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain ( BARD1 ) gene are associated with breast cancer susceptibility: a case-control analysis

Deleted in Breast Cancer 1 As a Potential Prognostic Biomarker in Human Cancers: a Pooled Analysis of 2,254 Patients.

BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility

Association Of Three Common Bard1 Variants With Cancer Susceptibility: A System Review And Meta-Analysis

Potential Roles of PBRM1 on Immune Infiltration in Cholangiocarcinoma.

Pan-cancer Analysis of the Prognostic and Immunological Role of BRCA1-associated Protein 1 Gene (BAP1): Friend or Foe?

Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients

Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis

Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis

CRL4-DCAF8L2 E3 Ligase Promotes Ubiquitination and Degradation of BARD1

Genetic and Functional Studies of Genes That Regulate DNA-Damage-Induced Cell Death

Prognostic Value Estimation of BRIP1 in Breast Cancer by Exploiting Transcriptomics Data Through Bioinformatics Approaches

Comprehensive Analysis of the Significance of Breast Cancer Gene 1 (BRCA-1) in Bladder Cancer